Jubilant Ingrevia Board Approves Final Dividend and Re-appoints Cost Auditors

Jubilant Ingrevia’s Board of Directors has recommended a final dividend of 250% (₹2.50 per share) for the fiscal year ended March 31, 2026. The record date for this dividend has been set for Friday, July 24, 2026. Additionally, the Board approved the re-appointment of M/s J.K. Kabra & Co. as the Company’s Cost Auditors for the Financial Year 2026-27.

Board Meeting Outcomes

Jubilant Ingrevia Limited announced the outcomes of its Board of Directors meeting held on Tuesday, May 26, 2026. The meeting, which commenced at 11:10 a.m. and concluded at 02:30 p.m., addressed several key corporate actions.

Dividend Recommendation

The Board recommended a final dividend of 250%, equivalent to ₹2.50 per equity share of ₹1/- each, for the financial year ended March 31, 2026. This dividend, subject to shareholder approval at the Annual General Meeting (AGM), is expected to be paid or dispatched within 30 days from the AGM date.

Record Date Fixed

In connection with the final dividend payment, the Board has fixed Friday, July 24, 2026, as the record date.

Cost Auditors Re-appointed

Furthermore, the re-appointment of M/s J.K. Kabra & Co. as Cost Accountants (Registration no. 9, ICWA) has been approved. They will serve as the Cost Auditors for the Company for the Financial Year 2026-27. Details regarding this re-appointment are provided in Annexure-A, as per the SEBI Master Circular.

Annexure A: Cost Auditor Details

M/s J.K. Kabra & Co., Cost Auditors

Reason for Change: Re-appointment for the financial year 2026-27.

Date of Re-appointment and Terms: May 26, 2026, for the financial year 2026-27.

Brief Profile: M/s J.K. Kabra & Co. is a leading Cost Accounting firm in India with its registered office in Delhi and offices in Surat and Mumbai. The firm possesses diverse experience in Cost Audit, Costing Systems, Inventory Valuation, Stock Audit, and Internal Audit. They have a strong portfolio of national companies and a reputation for integrity, independence, and providing valuable insights through their professional team.

Disclosure of Relationship between Directors: Not Applicable.

Source: BSE

Previous Article

Vaibhav Global Limited Schedule of Investor/Analyst Meet Announced

Next Article

Aarti Pharmalabs Limited Q4 FY26 Results Presentation Filed